{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:29:38Z","timestamp":1789842578716,"version":"4.0.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004830","name":"Siemens","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004830","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.msard.2020.102403","type":"journal-article","created":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T02:19:33Z","timestamp":1594952373000},"page":"102403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["Validation of inter-eye difference thresholds in optical coherence tomography for identification of optic neuritis in multiple sclerosis"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0825-0851","authenticated-orcid":false,"given":"Gabriel","family":"Bsteh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2833-6337","authenticated-orcid":false,"given":"Harald","family":"Hegen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Altmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Auer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Berek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Zinganell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska Di","family":"Pauli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5209-6647","authenticated-orcid":false,"given":"Paulus","family":"Rommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4541-8841","authenticated-orcid":false,"given":"Florian","family":"Deisenhammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fritz","family":"Leutmezer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.msard.2020.102403_bib0001","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1007\/s00415-017-8531-y","article-title":"Retinal ganglion cell analysis in multiple sclerosis and optic neuritis: a systematic review and meta-analysis","volume":"264","author":"Britze","year":"2017","journal-title":"J. Neurol."},{"issue":"12","key":"10.1016\/j.msard.2020.102403_bib0002","doi-asserted-by":"crossref","first-page":"e1130","DOI":"10.1212\/WNL.0000000000006207","article-title":"Inclusion of optic nerve involvement in dissemination in space criteria for multiple sclerosis","volume":"91","author":"Brownlee","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2020.102403_bib0003","article-title":"Peripapillary retinal nerve fibre layer as measured by optical coherence tomography is a prognostic biomarker not only for physical but also for cognitive disability progression in multiple sclerosis","author":"Bsteh","year":"2017","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2020.102403_bib0004","doi-asserted-by":"crossref","DOI":"10.1111\/ene.13897","article-title":"Peripapillary retinal nerve fibre layer thinning rate as a biomarker discriminating stable and progressing relapsing-remitting multiple sclerosis","author":"Bsteh","year":"2019","journal-title":"Eur. J. Neurol. Published online"},{"issue":"2","key":"10.1016\/j.msard.2020.102403_bib0005","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0197-2456(93)90015-6","article-title":"Design, methods, and conduct of the optic neuritis treatment trial","volume":"14","author":"Cleary","year":"1993","journal-title":"Control. Clin. Trials"},{"key":"10.1016\/j.msard.2020.102403_bib0006","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2147\/EB.S139417","article-title":"Retinal imaging with optical coherence tomography: a biomarker in multiple sclerosis","volume":"10","author":"Costello","year":"2018","journal-title":"Eye Brain"},{"key":"10.1016\/j.msard.2020.102403_bib0007","doi-asserted-by":"crossref","DOI":"10.1002\/ana.20851","article-title":"Quantifying axonal loss after optic neuritis with optical coherence tomography","volume":"59","author":"Costello","year":"2006","journal-title":"Ann. Neurol."},{"issue":"24","key":"10.1016\/j.msard.2020.102403_bib0008","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1212\/WNL.0000000000002774","article-title":"The APOSTEL recommendations for reporting quantitative optical coherence tomography studies","volume":"86","author":"Cruz-Herranz","year":"2016","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.msard.2020.102403_bib0009","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11910-017-0725-2","article-title":"Trans-synaptic retrograde degeneration in the human visual system: slow, silent, and real","volume":"17","author":"Dinkin","year":"2017","journal-title":"Curr. Neurol. Neurosci."},{"issue":"3","key":"10.1016\/j.msard.2020.102403_bib0010","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S1474-4422(15)00393-2","article-title":"MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines","volume":"15","author":"Filippi","year":"2016","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.msard.2020.102403_bib0011","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ana.24351","article-title":"Dynamics of retinal injury after acute optic neuritis","volume":"77","author":"Gabilondo","year":"2015","journal-title":"Ann. Neurol."},{"issue":"06","key":"10.1016\/j.msard.2020.102403_bib0012","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1055\/s-0039-1700528","article-title":"Optical Coherence Tomography in Multiple Sclerosis","volume":"39","author":"Graves","year":"2019","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.msard.2020.102403_bib0013","doi-asserted-by":"crossref","unstructured":"Group ETDRSR.Photocoagulation for diabetic macular edema. early treatment diabetic retinopathy study report number 1. Arch. Ophthalmol.-chic.. 1985;103(12):1796. doi:10.1001\/archopht.1985.01050120030015.","DOI":"10.1001\/archopht.1985.01050120030015"},{"issue":"10","key":"10.1016\/j.msard.2020.102403_bib0014","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1177\/1352458514524293","article-title":"Optical coherence tomography and visual evoked potentials: which is more sensitive in multiple sclerosis","volume":"20","author":"Maggio","year":"2014","journal-title":"Mult. Scler. J"},{"issue":"1","key":"10.1016\/j.msard.2020.102403_bib0015","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/WNL.0b013e3181aaea32","article-title":"Optical coherence tomography is less sensitive than visual evoked potentials in optic neuritis","volume":"73","author":"Naismith","year":"2009","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.msard.2020.102403_bib0016","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/WNO.0000000000000629","article-title":"Optimal intereye difference thresholds in retinal nerve fiber layer thickness for predicting a unilateral optic nerve lesion in multiple sclerosis","volume":"38","author":"Nolan","year":"2018","journal-title":"J. Neuro. Ophthalmol."},{"issue":"5","key":"10.1016\/j.msard.2020.102403_bib0017","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ana.25462","article-title":"Optimal intereye difference thresholds by optical coherence tomography in multiple sclerosis: an international study","volume":"85","author":"Nolan-Kenney","year":"2019","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2020.102403_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13311-016-0479-6","article-title":"Imaging as an outcome measure in multiple sclerosis","volume":"14","author":"Ontaneda","year":"2017","journal-title":"Neurotherapeutics"},{"issue":"10","key":"10.1016\/j.msard.2020.102403_bib0019","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1474-4422(17)30278-8","article-title":"Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis","volume":"16","author":"Petzold","year":"2017","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.msard.2020.102403_bib0020","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/1352458514538110","article-title":"Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria","volume":"21","author":"Schippling","year":"2014","journal-title":"Mult. Scler. J."},{"issue":"4","key":"10.1016\/j.msard.2020.102403_bib0021","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1167\/iovs.03-1213","article-title":"Subclinical visual involvement in multiple sclerosis: a study by MRI, VEPs, frequency-doubling perimetry, standard perimetry, and contrast sensitivity","volume":"46","author":"Sisto","year":"2005","journal-title":"Invest. Ophth. Vis. Sci."},{"issue":"4","key":"10.1016\/j.msard.2020.102403_bib0022","doi-asserted-by":"crossref","first-page":"e34823","DOI":"10.1371\/journal.pone.0034823","article-title":"The OSCAR-IB consensus criteria for retinal OCT quality assessment","volume":"7","author":"Tewarie","year":"2012","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.msard.2020.102403_bib0023","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.msard.2020.102403_bib0024","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199801293380502","article-title":"Axonal transection in the lesions of multiple sclerosis","volume":"338","author":"Trapp","year":"1998","journal-title":"New Engl. J. Med."},{"issue":"6","key":"10.1016\/j.msard.2020.102403_bib0025","doi-asserted-by":"crossref","first-page":"e527","DOI":"10.1212\/WNL.0000000000006873","article-title":"Optical coherence tomography is highly sensitive in detecting prior optic neuritis","volume":"92","author":"Xu","year":"2019","journal-title":"Neurology"},{"issue":"29","key":"10.1016\/j.msard.2020.102403_bib0026","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.1002\/sim.5889","article-title":"Using confidence intervals to compare several correlated areas under the receiver operating characteristic curves","volume":"32","author":"Zou","year":"2013","journal-title":"Stat. Med."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820304788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820304788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:50:57Z","timestamp":1761900657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034820304788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":26,"alternative-id":["S2211034820304788"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2020.102403","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of inter-eye difference thresholds in optical coherence tomography for identification of optic neuritis in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2020.102403","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102403"}}